A Pharmacodynamic and Safety Study of BCS in Healthy Volunteers

NCT ID: NCT02594449

Last Updated: 2015-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare pharmacodynamics among the different concentrations of BCS and NS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

2 times mouthwash in the morning and at night. To collect bacterium samples to assess the pharmacodynamics among the different concentrations of BCS and NS: observe the changes of aerobic bacterial colonization in oropharyngeal over time during 24 hours, and assess the improvement of oral healthy status and the subjective feelings after 24 hours.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

low concentration Benzalkonium Chloride

To use low concentration Benzalkonium Chloride Solution to gargle

Group Type ACTIVE_COMPARATOR

Benzalkonium Chloride Solution

Intervention Type DRUG

To compare pharmacodynamics among the different concentrations of BCS and NS

high concentration Benzalkonium Chloride

To use high concentration Benzalkonium Chloride Solution to gargle

Group Type ACTIVE_COMPARATOR

Benzalkonium Chloride Solution

Intervention Type DRUG

To compare pharmacodynamics among the different concentrations of BCS and NS

Normal Saline

To use Normal Saline to gargle

Group Type PLACEBO_COMPARATOR

Benzalkonium Chloride Solution

Intervention Type DRUG

To compare pharmacodynamics among the different concentrations of BCS and NS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Benzalkonium Chloride Solution

To compare pharmacodynamics among the different concentrations of BCS and NS

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Youkeshi

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteers, males or females.
* Females with U-HCG negative.
* Signed ICFs, and could conduct this study with investigators.

Exclusion Criteria

* History of mouthwash allergies, allergic rhinitis or dermatitis.
* Volunteers with oral ulcers, severe periodontal disease, oral mucosal lesions or oral cancer.
* Volunteers with removable denture.
* Had received special oral clean.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lustre Pharmaceutical Lab Co., Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shiyue Li, Professor

Role: PRINCIPAL_INVESTIGATOR

The First Affiliated Hospital of Guangzhou Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LC-PHB1505

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Burning Mouth Syndrome: Symptoms and Management
NCT07016555 RECRUITING EARLY_PHASE1
Effect of Octreotide on Saliva
NCT05340192 COMPLETED PHASE1